Efficacy and safety of antifibrotic agents for interstitial lung disease associated with rheumatoid arthritis - Trial UMIN000052195
Access comprehensive clinical trial information for UMIN000052195 through Pure Global AI's free database. This phase not specified trial is sponsored by Yokohama City University Graduate School of Medicine and is currently Not yet recruiting. The study focuses on Rheumatoid arthritis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000052195
Not yet recruiting
Trial Details
University Hospital Medical Information Network • UMIN000052195
Efficacy and safety of antifibrotic agents for interstitial lung disease associated with rheumatoid arthritis
Study Focus
Observational
Sponsor & Location
Yokohama City University Graduate School of Medicine
Japan
Timeline & Enrollment
N/A
Jan 01, 2024
N/A
ICD-10 Classifications
Rheumatoid arthritis, unspecified
Other rheumatoid arthritis
Other specified rheumatoid arthritis
Rheumatoid arthritis with involvement of other organs and systems
Seronegative rheumatoid arthritis
Data Source
University Hospital Medical Information Network
UMIN000052195
Non-Device Trial